Multiple Sclerosis Headlines
The BRAIN test is limited by its ability to only assess upper limb function.
While both intravenous and oral administrations of methylprednisolone showed similar efficacy, the investigators noted that oral administration may be more tolerable and cost-effective.
The FDA has granted Breakthrough Therapy designation to Fingolimod for treating children with relapsing multiple sclerosis.
Diet quality is associated with disability and symptom severity in multiple sclerosis patients.
Investigators believe this is the largest study on the association between multiple sclerosis and epilepsy.
While a useful biomarker, sampling of serum NfL requires multiple lumbar spine punctures.
For patients with MS and CCSVI, precutaneous transluminal angioplasty seems to be safe but not effective.
Peripheral nerve involvement can be visualized and quantified by high-resolution MRN in MS patients.
Investigators strived to determine the association between multiple sclerosis and Epstein-Barr virus or cytomegalovirus infection in certain racial groups.
Aubagio may cause delays in conversion to clinical definite MS by slowing the loss of cortical grey matter.
Patients experienced reduced disease activity when switched to alemtuzumab.
Patients with relapsing-remitting multiple sclerosis with high titers of JCV antibodies and who were being treated with natalizumab for more than 2 years were enrolled in the study.
Data show superiority of OCREVUS compared to Rebif in reducing disability progression independent of relapse activity in people with RMS.
Celgene announced new Phase 3 data evaluating the safety and efficacy of ozanimod vs Avonex for RMS.
There are no FDA-approved MS therapies for the pediatric population.
As early treatment of multiple sclerosis is crucial, it is important to identify the factors that may delay diagnosis.
An emerging line of inquiry suggests a potential association between comorbidities and MS relapses, but studies have been limited.
Patients with multiple sclerosis who experience severe fatigue should be screened for obstructive sleep apnea.
In patients with multiple sclerosis, lesions in the right dorsolateral prefrontal cortex may be associated with hypoalgesia, and lesions in the posterior periventricular area, with hyperalgesia.
Researchers believe that environmental factors may impact disease severity characteristics in genetically susceptible populations.
Neurology Advisor Articles
- Guidelines: AAN Recommends Exercise, Cautious Prescribing for Patients With Mild Cognitive Impairment
- Galcanezumab Significantly Reduces Migraine Headaches vs Placebo
- Noninvasive Vagus Nerve Stimulation Effective for Episodic Cluster Headaches
- Migraine Risk Significantly Reduced With Investigational Drug
- Guidelines: Opioids for the Treatment of Refractory Restless Legs Syndrome
- Treating Levetiracetam-Induced Behavioral Effects With Vitamin B6
- Apixaban Not Superior to Warfarin for Reducing Stroke Risk in Atrial Fibrillation
- Electrostimulation Plus Task Training Improves Upper Limb Function After Stroke
- Stroke Neurocognitive Outcomes Improved With Gingko Biloba Extract
- Subcortical Microinfarcts Associated With Decreased Blood Pressure in Elderly